Skip to main content

Advertisement

Log in

Association study of CD154 polymorphisms and serum CD154 level with systemic lupus erythematous in Chinese population

  • Genes and disease
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The aim of this study was to investigate the association of three polymorphisms of CD154 with risk of SLE in Chinese population. The study population comprised 770 Chinese individuals, including 350 SLE patients and 420 healthy controls. The gene polymorphism was measured using Snapshot SNP genotyping assays and confirmed by sequencing. Serum CD154 (sCD154) level was measured by ELISA. Compared with control group, sCD154 levels were significantly increased in case group (P < 0.001). The minor C allele of rs1126535 was associated with a significantly increased risk of SLE as compared to the major T allele (P < 0.001). Furthermore, an increased frequency of C-G-A haplotype was also detected in case group which associated with an increased risk of SLE (P = 0.009). Notably, patients carrying rs1126535CT/CC genotypes had a higher sCD154 level compared with that carrying rs1126535TT genotype (P < 0.05). Unfortunately, analyses on the association between rs1126535 and several clinical manifestations of SLE failed to find any significant results. In conclusion, these results indicated that CD154 gene polymorphisms may associate with the risk of SLE and may play regulation role in the expression of sCD154 in SLE patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Aringer M et al (2016) Toward new criteria for systemic lupus erythematosus-a standpoint. Lupus 25(8):805–811

    Article  CAS  PubMed  Google Scholar 

  2. Wu M et al (2016) The Role of gammadelta T Cells in systemic lupus erythematosus. J Immunol Res 2016:2932531

    Article  PubMed  PubMed Central  Google Scholar 

  3. Araujo JA et al (2016) Th17 cells and CD4(+) multifunctional T cells in patients with systemic lupus erythematosus. Rev Bras Reumatol (Rio J) 56(1):28–36

    Article  Google Scholar 

  4. Andrade D et al (2015) Interferon-alpha and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia. Arthritis Rheumatol 67(4):977–987

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Zhu X et al (2015) Role of abnormal anterior pituitary hormones-growth hormone and prolactin in active systemic lupus erythematosus. Int J Clin Exp Med 8(10):19223–19231

    PubMed  PubMed Central  Google Scholar 

  6. Abdallah E, Waked E, Abdelwahab MA (2016) Evaluating the association of interleukin-10 gene promoter -592 A/C polymorphism with lupus nephritis susceptibility. Kidney Res Clin Pract 35(1):29–34

    Article  PubMed  Google Scholar 

  7. Al-Rayes H et al (2016) Apolipoprotein E Gene polymorphisms in saudi patients with systemic lupus erythematosus. Clin Med Insights Arthritis Musculoskelet Disord 9:81–87

    PubMed  PubMed Central  Google Scholar 

  8. Shahin RM et al (2016) Contribution of toll-like receptor 9 gene single-nucleotide polymorphism to systemic lupus erythematosus in Egyptian Patients. Immunol Invest 45(3):235–242

    Article  PubMed  Google Scholar 

  9. Senhaji N et al (2015) The contribution of CD40/CD40L axis in inflammatory bowel disease: an update. Front Immunol 6:529

    Article  PubMed  PubMed Central  Google Scholar 

  10. Oxer DS et al (2011) PPARgamma expression is increased in systemic lupus erythematosus patients and represses CD40/CD40L signaling pathway. Lupus 20(6):575–587

    Article  CAS  PubMed  Google Scholar 

  11. Liu MF et al (2001) Expression of CD40 and CD40 ligand among cell populations within rheumatoid synovial compartment. Autoimmunity 34(2):107–113

    Article  CAS  PubMed  Google Scholar 

  12. Nakamura H, Kawakami A, Eguchi K (2006) Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjogren’s syndrome. Transl Res 148(6):281–288

    Article  CAS  PubMed  Google Scholar 

  13. Toubi E, Shoenfeld Y (2004) The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 37(6–7):457–464

    Article  CAS  PubMed  Google Scholar 

  14. Xu H et al (2015) Increased frequency of circulating follicular helper T cells in lupus patients is associated with autoantibody production in a CD40L-dependent manner. Cell Immunol 295(1):46–51

    Article  CAS  PubMed  Google Scholar 

  15. Willis R et al (2014) Effects of statins on proinflammatory/prothrombotic biomarkers and on disease activity scores in SLE patients: data from LUMINA (LXXVI), a multi-ethnic US cohort. Clin Exp Rheumatol 32(2):162–167

    CAS  PubMed  Google Scholar 

  16. Willis R et al (2012) Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort. Lupus 21(8):830–835

    Article  CAS  PubMed  Google Scholar 

  17. Goules A et al (2006) Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases. J Autoimmun 26(3):165–171

    Article  CAS  PubMed  Google Scholar 

  18. Ciferska H et al (2007) The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value. Clin Rheumatol 26(5):723–728

    Article  PubMed  Google Scholar 

  19. Urquizu-Padilla M et al (2009) Serum levels of soluble CD40 ligand at flare and at remission in patients with systemic lupus erythematosus. J Rheumatol 36(5):953–960

    Article  CAS  PubMed  Google Scholar 

  20. Chen JM et al (2015) The association of CD40 polymorphisms with CD40 serum levels and risk of systemic lupus erythematosus. BMC Genet 16:121

    Article  PubMed  PubMed Central  Google Scholar 

  21. Lee SH et al (2014) The Interaction Between Allelic Variants of CD86 and CD40LG: a common risk factor of allergic asthma and rheumatoid arthritis. Allergy Asthma Immunol Res 6(2):137–141

    Article  PubMed  Google Scholar 

  22. Teruel M et al (2012) Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis. Arthritis Res Ther 14(3):R154

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Chadha S et al (2005) Haplotype structure of TNFRSF5-TNFSF5 (CD40-CD40L) and association analysis in systemic lupus erythematosus. Eur J Hum Genet 13(5):669–676

    Article  CAS  PubMed  Google Scholar 

  24. Citores MJ et al (2004) The dinucleotide repeat polymorphism in the 3′UTR of the CD154 gene has a functional role on protein expression and is associated with systemic lupus erythematosus. Ann Rheum Dis 63(3):310–317

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Wang N, Peng XB, Zeng K (2007) Effect of prolactin on CD40/CD154 expression on peripheral blood mononuclear cells in patients with systemic lupus erythematosus. Nan Fang Yi Ke Da Xue Xue Bao 27(9):1382–1384

    CAS  PubMed  Google Scholar 

  26. Rider V et al (2001) Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus. J Rheumatol 28(12):2644–2649

    CAS  PubMed  Google Scholar 

  27. Li X et al (2006) Estrogen does not regulate CD154 mRNA stability in systemic lupus erythematosus T cells. Lupus 15(12):852–857

    Article  CAS  PubMed  Google Scholar 

  28. Wang M et al (2009) Functional activation of proline-rich tyrosine kinase2 (PYK2) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. BMC Musculoskelet Disord 10:141

    Article  PubMed  PubMed Central  Google Scholar 

  29. Wang M, Zhang W, Zhang Y (2009) Activation signal transduction by proline-rich tyrosine kinase 2 (PYK2) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Hybridoma (Larchmt) 28(5):333–339

    Article  CAS  Google Scholar 

  30. Peeva E et al (2006) Cutting edge: lupus susceptibility interval Sle3/5 confers responsiveness to prolactin in C57BL/6 mice. J Immunol 177(3):1401–1405

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by National Natural Science Foundation of China (No. 81260234, No. 81560552).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yan Lan.

Ethics declarations

Conflict of interest

Author Yan Lan has received research grants from National Natural Science Foundation of China (grant number 81260234). Author Ye-Sheng Wei has received research grants from National Natural Science Foundation of China (grant number 81560552). All the authors declare that they have no conflict of interest.

Funding

This study was funded by National Natural Science Foundation of China (grant number 81260234, 81560552).

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xiang, Y., Guo, J., Peng, YF. et al. Association study of CD154 polymorphisms and serum CD154 level with systemic lupus erythematous in Chinese population. Rheumatol Int 37, 1287–1294 (2017). https://doi.org/10.1007/s00296-017-3745-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-017-3745-y

Keywords

Navigation